Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data?

Abstract The use of new psychoactive substances (NPS) is increasing and currently > 600 NPS have been reported. However, limited information on neuropharmacological and toxicological effects of NPS is available, hampering risk characterization. We reviewed the literature on the in vitro neuronal modes of action to obtain effect fingerprints of different classes of illicit drugs and NPS. The most frequently reported NPS were selected for review: cathinones (MDPV, &agr;‐PVP, mephedrone, 4‐MEC, pentedrone, methylone), cannabinoids (JWH‐018), (hallucinogenic) phenethylamines (4‐fluoroamphetamine, benzofurans (5‐APB, 6‐APB), 2C‐B, NBOMes (25B‐NBOMe, 25C‐NBOMe, 25I‐NBOMe)), arylcyclohexylamines (methoxetamine) and piperazine derivatives (mCPP, TFMPP, BZP). Our effect fingerprints highlight the main modes of action for the different NPS studied, including inhibition and/or reversal of monoamine reuptake transporters (cathinones and non‐hallucinogenic phenethylamines), activation of 5‐HT2receptors (hallucinogenic phenethylamines and piperazines), activation of cannabinoid receptors (cannabinoids) and inhibition of NDMA receptors (arylcyclohexylamines). Importantly, we identified additional targets by relating reported effect concentrations to the estimated human brain concentrations during recreational use. These additional targets include dopamine receptors, &agr;‐ and &bgr;‐adrenergic receptors, GABAAreceptors and acetylcholine receptors, which may all contribute to the observed clinical symptoms following exposure. Additional data is needed as the number of NPS continues to increase. Also, the effect fingerprints we have obtained are still incomplete and suffer from a large variation in the reported effects and effect sizes. Dedicated in vitro screening batteries will aid in complementing specific effect fingerprints of NPS. These fingerprints can be implemented in the risk assessments of NPS that are necessary for eventual control measures to reduce Public Health risks.

• Publication year

  2017

• Venue

  Pharmacology and Therapeutics

• Publication date

  2017-10-31

• Fields of study

  Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1016/j.pharmthera.2017.10.022PMID 29097307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2006 Annual report: the state of the drugs problem in Europe

  2019cited by this paper
• Comparing the dopaminergic neurotoxic effects of benzylpiperazine and benzoylpiperazine

  2018cited by this paper
• Experimental Study on the Postmortem Redistribution of the Substituted Phenethylamine, 25B‐NBOMe

  2018cited by this paper
• 1 New therapeutic opportunities for 5-HT 2 receptor ligands

  2018cited by this paper
• Atypical dopamine efflux caused by 3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporter.

  2017cited by this paper
• Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization

  2017cited by this paper
• Measuring inhibition of monoamine reuptake transporters by new psychoactive substances (NPS) in real-time using a high-throughput, fluorescence-based assay.

  2017cited by this paper
• Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties

  2017cited by this paper
• NMDA receptors: linking physiological output to biophysical operation

  2017cited by this paper
• Characterization of structurally novel G protein biased CB1 agonists: Implications for drug development

  2017cited by this paper
• Synthesis and N-Methyl-d-aspartate (NMDA) Receptor Activity of Ketamine Metabolites.

  2017cited by this paper
• Fatalities, Cerebral Hemorrhage, and Severe Cardiovascular Toxicity After Exposure to the New Psychoactive Substance 4‐Fluoroamphetamine: A Prospective Cohort Study

  2017cited by this paper
• Synthesis, characterization and monoamine transporter activity of the new psychoactive substance mexedrone and its N-methoxy positional isomer, N-methoxymephedrone.

  2017cited by this paper
• Neurotoxicity of β-Keto Amphetamines: Deathly Mechanisms Elicited by Methylone and MDPV in Human Dopaminergic SH-SY5Y Cells.

  2017cited by this paper
• 2,5-dimethoxy-4-chloroamphetamine, a LSD-like designer drug: Clinical and analytical documentation of non-fatal exposure in five patients

  2017cited by this paper
• Bad trip due to 25I-NBOMe: a case report from the EU project SPICE II plus

  2017cited by this paper
• Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens.

  2017cited by this paper
• Brain cannabinoid receptor 2: expression, function and modulation

  2017cited by this paper
• Pharmacokinetic Profiles and Pharmacodynamic Effects for Methylone and Its Metabolites in Rats

  2017cited by this paper
• Pharmacological profile of mephedrone analogs and related new psychoactive substances.

  2017cited by this paper
• Ketamine Increases the Function of &ggr;-Aminobutyric Acid Type A Receptors in Hippocampal and Cortical Neurons

  2017cited by this paper
• The occurrence of alcohol/drugs by toxicological examination of selected drivers in Hong Kong.

  2017cited by this paper
• Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release

  2017cited by this paper
• Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences

  2017cited by this paper
• Acute toxic effects related to 4-fluoroamphetamine.

  2017cited by this paper
• A literature review of blood concentrations of new psychoactive substances classified as phenethylamines, aminoindanes, arylalkylamines, arylcyclohexylamines, and indolalkylamines.

  2017cited by this paper
• Neuropharmacological characterization of the new psychoactive substance methoxetamine

  2017cited by this paper
• “Bath Salts” the New York City Medical Examiner Experience: A 3‐Year Retrospective Review

  2017cited by this paper
• Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight.

  2017cited by this paper
• Ketamine attenuates the glutamatergic neurotransmission in the ventral posteromedial nucleus slices of rats

  2017cited by this paper
• Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.

  2017cited by this paper
• Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters

  2016cited by this paper
• Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues.

  2016cited by this paper
• In vitro neurotoxicity evaluation of piperazine designer drugs in differentiated human neuroblastoma SH‐SY5Y cells

  2016cited by this paper
• 5-HT2A/5-HT2C Receptor Pharmacology and Intrinsic Clearance of N-Benzylphenethylamines Modified at the Primary Site of Metabolism.

  2016cited by this paper
• Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project

  2016cited by this paper
• Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay.

  2016cited by this paper
• Phase I metabolites of mephedrone display biological activity as substrates at monoamine transporters

  2016cited by this paper
• Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135.

  2016cited by this paper
• Blood concentrations of α-pyrrolidinovalerophenone (α-PVP) determined in 66 forensic samples

  2016cited by this paper
• Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies

  2016cited by this paper
• Disruption of hippocampal synaptic transmission and long‐term potentiation by psychoactive synthetic cannabinoid ‘Spice’ compounds: comparison with Δ9‐tetrahydrocannabinol

  2016cited by this paper
• The prevalence of new psychoactive substances in biological material - a three-year review of casework in Poland.

  2016cited by this paper
• Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis.

  2016cited by this paper
• Is the time right for in vitro neurotoxicity testing using human iPSC-derived neurons?

  2016cited by this paper
• Case series: toxicity from 25B-NBOMe – a cluster of N-bomb cases

  2016cited by this paper
• Ketamine abuse potential and use disorder.

  2016cited by this paper
• Detailed pharmacological evaluation of methoxetamine (MXE), a novel psychoactive ketamine analogue-Behavioural, pharmacokinetic and metabolic studies in the Wistar rat.

  2016cited by this paper
• Trade hub to innovation hotbed: The southern Chinese city of Guangzhou is fast becoming an epicentre for scientists and researchers to join forces with industry to develop new high-tech products and innovations.

  2016cited by this paper
• New therapeutic opportunities for 5‐HT2 receptor ligands

  2016cited by this paper
• Neurochemical binding profiles of novel indole and benzofuran MDMA analogues

  2016cited by this paper
• Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice.

  2016cited by this paper
• Detection of 25C-NBOMe in Three Related Cases.

  2016cited by this paper
• Cardiac N-methyl D-aspartate Receptors as a Pharmacological Target

  2016cited by this paper
• Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings

  2016cited by this paper
• Neurotoxicity screening of (illicit) drugs using novel methods for analysis of microelectrode array (MEA) recordings.

  2016cited by this paper
• NMDAR inhibition-independent antidepressant actions of ketamine metabolites

  2016cited by this paper
• Ketamine Inhibits ATP-Evoked Exocytotic Release of Brain-Derived Neurotrophic Factor from Vesicles in Cultured Rat Astrocytes

  2016cited by this paper
• A REVIEW OF KETAMINE ABUSE AND DIVERSION

  2016influential reference
• Cytotoxic Activity of Pyrovalerone Derivatives, an Emerging Group of Psychostimulant Designer Cathinones

  2016cited by this paper
• Antagonist pharmacology of desensitizing and non-desensitizing nicotinic acetylcholine receptors in cockroach neurons.

  2016cited by this paper
• A Fatal Case of Pentedrone and α-Pyrrolidinovalerophenone Poisoning.

  2015cited by this paper
• Structural Modification of the Designer Stimulant α-Pyrrolidinovalerophenone (α-PVP) Influences Potency at Dopamine Transporters.

  2015cited by this paper
• 4-Fluoroamphetamine in the Netherlands: more than a one-night stand.

  2015cited by this paper
• Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones.

  2015cited by this paper
• Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid.

  2015cited by this paper
• Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse

  2015cited by this paper
• Follow Me Down the K-hole: Ketamine and Its Modern Applications

  2015cited by this paper
• Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA.

  2015cited by this paper
• Postnatal Phencyclidine (PCP) as a Neurodevelopmental Animal Model of Schizophrenia Pathophysiology and Symptomatology: A Review.

  2015influential reference
• The Endocannabinoid System and its Modulation by Phytocannabinoids

  2015cited by this paper
• Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor.

  2015cited by this paper
• The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.

  2015cited by this paper
• Novel Potent N-Methyl-d-aspartate (NMDA) Receptor Antagonists or σ1 Receptor Ligands Based on Properly Substituted 1,4-Dioxane Ring.

  2015cited by this paper
• “Second generation” mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function

  2015cited by this paper
• Stereochemistry of mephedrone neuropharmacology: enantiomer‐specific behavioural and neurochemical effects in rats

  2015cited by this paper
• Potencies and unblocking kinetic properties of antagonists at recombinant human NMDA receptors in a Xenopus oocytes model

  2015cited by this paper
• Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs).

  2015cited by this paper
• Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice.

  2015cited by this paper
• Antidepressant actions of ketamine: from molecular mechanisms to clinical practice.

  2015cited by this paper
• Presynaptic NMDA receptors: Roles and rules.

  2015cited by this paper
• Ketamine and phencyclidine: the good, the bad and the unexpected

  2015cited by this paper
• The global drug survey 2015 findings.

  2015influential reference
• Stereoselective Actions of Methylenedioxypyrovalerone (MDPV) To Inhibit Dopamine and Norepinephrine Transporters and Facilitate Intracranial Self-Stimulation in Rats.

  2015cited by this paper
• Mitochondrial respiratory dysfunction due to the conversion of substituted cathinones to methylbenzamides in SH-SY5Y cells

  2015cited by this paper
• Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel

  2015cited by this paper
• Pharmacological profile of novel psychoactive benzofurans

  2015cited by this paper
• Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine.

  2015cited by this paper
• Structure-dependent inhibition of the human α1β2γ2 GABAA receptor by piperazine derivatives: A novel mode of action.

  2015cited by this paper
• ‘Second-Generation’ Mephedrone Analogs, 4-MEC and 4-MePPP, Differentially Affect Monoamine Transporter Function

  2015cited by this paper
• Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MSn techniques

  2015cited by this paper
• Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135.

  2015cited by this paper
• Monoamine transporter and receptor interaction profiles of a new series of designer cathinones.

  2014cited by this paper
• Sudden unexpected death under acute influence of cannabis.

  2014cited by this paper
• Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).

  2014cited by this paper
• Treatment with a Monoclonal Antibody against Methamphetamine and Amphetamine Reduces Maternal and Fetal Rat Brain Concentrations in Late Pregnancy

  2014cited by this paper
• Ketamine: an update on its abuse.

  2014cited by this paper
• Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention.

  2014cited by this paper
• The preclinical pharmacology of mephedrone; not just MDMA by another name

  2014cited by this paper
• Mephedrone and other cathinones

  2014influential reference

• New psychoactive substances: a multidisciplinary review of challenges and their diverse character

  2025cites this paper
• Pharmacological Effects and Pharmacokinetics of the Novel Synthetic Cathinone α-Pyrrolidinoisohexanophenone (α-PiHP) Compared with α-Pyrrolidinovalerophenone (α-PVP) in Mice.

  2025cites this paper
• Acute cathinone poisoning: epidemiology, pathogenesis, clinical picture, diagnosis and treatment principles (literature review)

  2025cites this paper
• Methylone regulates fear memory and amygdala activity: A potential treatment for posttraumatic stress disorder?

  2024cites this paper
• Polymorphism of Bis(benzimidazole)bis(thiocyanato-N)cobalt(II) and Its Relevance to Studies of the Chief Color Test for Cocaine

  2024cites this paper
• Uncovering Structure-Activity Relationships of Phenethylamines: Paving the Way for Innovative Mental Health Treatments.

  2024cites this paper
• In Vitro Activation of Human Adrenergic Receptors and Trace Amine-Associated Receptor 1 by Phenethylamine Analogues Present in Food Supplements

  2024cites this paper
• Psychedelic-related deaths in England, Wales and Northern Ireland (1997-2022).

  2024cites this paper
• On the utilization of the induced pluripotent stem cell (iPSC) model to study substance use disorders: A scoping review protocol

  2023cites this paper
• METHYLONE PRODUCES ANTIDEPRESSANT-RELEVANT ACTIONS AND PROSOCIAL EFFECTS

  2023cites this paper
• Methylone, a rapid acting entactogen with robust anxiolytic and antidepressant-like activity

  2023cites this paper
• Pharmaco-Toxicological Effects of Atypical Synthetic Cathinone Mephtetramine (MTTA) in Mice: Possible Reasons for Its Brief Appearance over NPSs Scene

  2023cites this paper
• Applications and Potential of In Silico Approaches for Psychedelic Chemistry

  2023cites this paper
• 4-EA-NBOMe, an amphetamine derivative, alters glutamatergic synaptic transmission through 5-HT1A receptors on cortical neurons from SpragueDawley rat and pyramidal neurons from C57BL/6 mouse.

  2023cites this paper
• Metabolism of dipentylone in zebrafish and human liver microsomes determined by liquid chromatography-high resolution mass spectrometry.

  2023cites this paper
• Effect of -NBOMe Compounds on Sensorimotor, Motor, and Prepulse Inhibition Responses in Mice in Comparison With the 2C Analogs and Lysergic Acid Diethylamide: From Preclinical Evidence to Forensic Implication in Driving Under the Influence of Drugs

  2022influential citation
• Pharmacology and toxicology of N-Benzyl-phenylethylamines (25X-NBOMe) hallucinogens

  2022cites this paper
• The Novel Psychoactive Substances Epidemic: a Scientometric Perspective

  2022cites this paper
• Pharmacological profiling of novel psychoactive substances

  2022cites this paper
• An Update on the Implications of New Psychoactive Substances in Public Health

  2022influential citation
• Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs

  2022cites this paper
• Enantioselectivity of Pentedrone and Methylone on Metabolic Profiling in 2D and 3D Human Hepatocyte-like Cells

  2022cites this paper
• Cognitive Deficits and Synthetic Khat-Related Cathinones

  2022cites this paper
• In vitro metabolic profile of mexedrone, a mephedrone analog, studied by high‐ and low‐resolution mass spectrometry

  2021cites this paper
• A Comparison of Acute Pharmacological Effects of Methylone and MDMA Administration in Humans and Oral Fluid Concentrations as Biomarkers of Exposure

  2021cites this paper
• In Vitro and In Vivo Pharmaco-Toxicological Characterization of 1-Cyclohexyl-x-methoxybenzene Derivatives in Mice: Comparison with Tramadol and PCP

  2021cites this paper
• Serotonin toxicity of serotonergic psychedelics

  2021cites this paper
• Human Neuronal Cell Lines as An In Vitro Toxicological Tool for the Evaluation of Novel Psychoactive Substances

  2021cites this paper
• Machine learning vs. field 3D-QSAR models for serotonin 2A receptor psychoactive substances identification

  2021cites this paper
• Synthetic cannabinoids in e-liquids: A proton and fluorine NMR analysis from a conventional spectrometer to a compact one.

  2021cites this paper
• Synthesis and Functional Characterization of 2-(2,5-Dimethoxyphenyl)-N-(2-fluorobenzyl)ethanamine (25H-NBF) Positional Isomers.

  2021cites this paper
• Acute MDPV Binge Paradigm on Mice Emotional Behavior and Glial Signature

  2021cites this paper
• Low-normal doses of methiopropamine induce aggressive behaviour in mice

  2021cites this paper
• S-(+)-pentedrone and R-(+)-methylone as the most oxidative and cytotoxic enantiomers to dopaminergic SH-SY5Y cells: Role of MRP1 and P-gp in cathinones enantioselectivity.

  2021cites this paper
• Combining ecstasy and ethanol: higher risk for toxicity? A review

  2021influential citation
• Rapid Targeted Method of Detecting Abused Piperazine Designer Drugs

  2021influential citation
• Novel Psychoactive Phenethylamines: Impact on Genetic Material

  2020cites this paper
• Synthetic cathinones and their potential interactions with prescription drugs.

  2020cites this paper
• Hazard Characterization of Synthetic Cathinones Using Viability, Monoamine Reuptake, and Neuronal Activity Assays

  2020influential citation
• Novel Phenethylamines and their Potential Interactions with Prescription Drugs: A Systematic Critical Review.

  2020cites this paper
• Synthetic cathinones - From natural plant stimulant to new drug of abuse.

  2020cites this paper
• The rise of new psychoactive substances and psychiatric implications: A wide‐ranging, multifaceted challenge that needs far‐reaching common legislative strategies

  2020cites this paper
• Hyperthermia exacerbates the acute effects of psychoactive substances on neuronal activity measured using microelectrode arrays (MEAs) in rat primary cortical cultures in vitro.

  2020cites this paper
• Syntheses and analytical characterizations of novel (2-aminopropyl)benzo[b]thiophene (APBT) based stimulants.

  2020cites this paper
• Piperazine derivatives as dangerous abused compounds

  2020cites this paper
• Editorial: Hallucinogens and Entactogens: Establishing a New Class of Psychotherapeutic Drugs?

  2020cites this paper
• In vitro structure–activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor

  2020cites this paper
• Urinary excretion profile of methiopropamine in mice following intraperitoneal administration: a liquid chromatography-tandem mass spectrometry investigation.

  2020cites this paper
• Exploring the chemical profile of designer drugs by ESI(+) and PSI(+) mass spectrometry-An approach on the fragmentation mechanisms and chemometric analysis.

  2020cites this paper
• The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats

  2020cites this paper
• GC–MS analysis of methylenedioxybenzyl analogues of the serotonin receptor agonists 25X-NBOMe drugs

  2020cites this paper
• Acute onset heart failure due to reverse type Takotsubo cardiomyopathy caused by a single dose of 4-Fluoroamphetamine in a healthy young individual

  2020cites this paper
• Chemical classification of new psychoactive substances (NPS)

  2020cites this paper
• New psychoactive substances: a review and updates

  2020cites this paper
• The SERT Met172 Mouse: An Engineered Model To Elucidate the Contributions of Serotonin Signaling to Cocaine Action.

  2019cites this paper
• A First-in-Man Study with 4-Fluoroamphetamine Demonstrates it Produces a Mild Psychedelic State

  2019cites this paper
• Impact of ketamine on the behavior and immune system of adult medaka (Oryzias latipes) at environmentally relevant concentrations and eco-risk assessment in surface water.

  2019cites this paper
• Should NPS be included in workplace drug testing?

  2019cites this paper
• Piperazine designer drugs elicit toxicity in the alternative in vivo model Caenorhabditis elegans

  2019cites this paper
• Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies

  2019cites this paper
• No Influence of Dopamine System Gene Variations on Acute Effects of MDMA

  2019cites this paper
• Mix of new substances psychoactive, NPS, found in blotters sold in two Colombian cities.

  2019cites this paper
• Cardiotoxicity screening of illicit drugs and new psychoactive substances (NPS) in human iPSC-derived cardiomyocytes using microelectrode array (MEA) recordings.

  2019cites this paper
• New Psychoactive Substances: A Matter of Time

  2019cites this paper
• Structure-cytotoxicity relationship profile of 13 synthetic cathinones in differentiated human SH-SY5Y neuronal cells.

  2019cites this paper
• Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists.

  2019cites this paper
• Acute and repeated administration of MDPV increases aggressive behavior in mice: forensic implications

  2019cites this paper
• Changes in neuronal activity in rat primary cortical cultures induced by illicit drugs and new psychoactive substances (NPS) following prolonged exposure and washout to mimic human exposure scenarios.

  2019cites this paper
• Differential effects of psychoactive substances on human wildtype and polymorphic T356M dopamine transporters (DAT).

  2019cites this paper
• Role of the nitrogen terminus of pentiophenone derivatives (synthetic cathinones) inducing psychostimulant and rewarding effects

  2019cites this paper
• Drug liking and wanting, not impulsive action or reflection is increased by 4-fluoroamphetamine

  2018cites this paper
• KVANTITATIVNO ODREĐIVANJE SINTETSKIH KATINONA

  2018cites this paper
• Using Ca2+-channel biosensors to profile amphetamines and cathinones at monoamine transporters: electro-engineering cells to detect potential new psychoactive substances

  2018cites this paper
• Independent elevation of peripheral oxytocin concentrations and reduction in cognitive empathy during 4‐fluoroamphetamine intoxication

  2018cites this paper
• 1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances.

  2018cites this paper
• Safety Profile and Neurocognitive Function Following Acute 4-Fluoroamphetamine (4-FA) Administration in Humans

  2018cites this paper
• Neurotoxicity screening of new psychoactive substances (NPS): Effects on neuronal activity in rat cortical cultures using microelectrode arrays (MEA)

  2018cites this paper